Legal & General Group »

Enliven Therapeutics shares owned by Legal & General Group

Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Legal & General Group from 13F filings

Historical chart of Legal & General Group investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by Legal & General Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by Legal & General Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $272k 20k 13.84
2023-09-30 $269k 20k 13.66
2023-06-30 $369k 18k 20.41